Regulation of foamy viral transcription and RNA export

Advances in Virus Research

Volumn 81, Issue , 2011, Pages 1-31

  Bodem, Jochen ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Env transcripts; Foamy viral transcription; Foamy viruses; LTR promoter; Polyadenylation; Retroviruses; RNA export; Tas structure

Indexed keywords

EID: 81155138267     PISSN: 00653527     EISSN: 15578399     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385885-6.00006-7     Document Type: Chapter

References (161)

1. Achong B.G., Mansell P.W., Epstein M.A. A new human virus in cultures from a nasopharyngeal carcinoma. J. Pathol. 1971, 103:P18.
2. Ahmed Y.F., Hanly S.M., Malim M.H., Cullen B.R., Greene W.C. Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: Insights into the mechanism of Rex and Rev action. Genes Dev. 1990, 4:1014-1022.
3. Ahmed Y.F., Gilmartin G.M., Hanly S.M., Nevins J.R., Greene W.C. The HTLV-I Rex response element mediates a novel form of mRNA polyadenylation. Cell 1991, 64:727.
4. Ashe M.P., Griffin P., James W., Proudfoot N.J. Poly(A) site selection in the HIV-1 provirus: Inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev. 1995, 9:3008.
5. Ashe M.P., Pearson L.H., Proudfoot N.J. The HIV-1 5' LTR poly(A) site is inactivated by U1 snRNP interaction with the downstream major splice donor site. EMBO J. 1997, 16:5752.
6. Ashe M.P., Furger A., Proudfoot N.J. Stem-loop 1 of the U1 snRNP plays a critical role in the suppression of HIV-1 polyadenylation. RNA 2000, 6:170.
7. Bannert H., Muranyi W., Ogryzko V.V., Nakatani Y., Flügel R.M. Coactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activator. BMC Mol. Biol. 2004, 5:16.
8. Basyuk E., Boulon S., Skou Pedersen F., Bertrand E., Vestergaard Rasmussen S. The packaging signal of MLV is an integrated module that mediates intracellular transport of genomic RNAs. J. Mol. Biol. 2005, 354:330.
9. Becker P.B. Nucleosome sliding: Facts and fiction. EMBO J. 2002, 21:4749.
10. Becker P.B., Horz W. ATP-dependent nucleosome remodeling. Annu. Rev. Biochem. 2002, 71:247.
11. Bex F., Gaynor R.B. Regulation of gene expression by HTLV-I Tax protein. Methods 1998, 16:83.
12. Bodem J., Löchelt M., Winkler I., Flower R.P., Delius H., Flügel R.M. Characterization of the spliced pol transcript of feline foamy virus: The splice acceptor site of the pol transcript is located in gag of foamy viruses. J. Virol. 1996, 70:9024.
13. Bodem J., Löchelt M., Delius H., Flügel R. Detection of subgenomic cDNAs and mapping of feline foamy virus mRNAs reveals complex patterns of transcription. Virology 1998, 244:417.
14. Bodem J., Kang Y., Flügel R.M. Comparative functional characterization of the feline foamy virus transactivator reveals its species specificity. Virology 2004, 318:32.
15. Bodem J., Kräusslich H.-G., Rethwilm A. Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription. J. Gen. Virol. 2007, 88:259.
16. Bodem J., Schied T., Gabriel R., Rammling M., Rethwilm A. Foamy virus nuclear RNA export is distinct from that of other retroviruses. J. Virol. 2011, 85:2333.
17. Bogerd H.P., Wiegand H.L., Yang J., Cullen B.R. Mutational definition of functional domains within the Rev homolog encoded by human endogenous retrovirus K. J. Virol. 2000, 74:9353.
18. Bohne J., Krausslich H.G. Mutation of the major 5' splice site renders a CMV-driven HIV-1 proviral clone Tat-dependent: Connections between transcription and splicing. FEBS Lett. 2004, 563:113.
19. Bohne J., Schambach A., Zychlinski D. New way of regulating alternative splicing in retroviruses: The promoter makes a difference. J. Virol. 2007, 81:3652.
20. Boyes J., Byfield P., Nakatani Y., Ogryzko V. Regulation of activity of the transcription factor GATA-1 by acetylation. Nature 1998, 396:594.
21. Bres V., Kiernan R., Emiliani S., Benkirane M. Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication. J. Biol. Chem. 2002, 277:22215.
22. Bres V., Tagami H., Peloponese J.M., Loret E., Jeang K.T., Nakatani Y., Emiliani S., Benkirane M., Kiernan R.E. Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF. EMBO J. 2002, 21:6811.
23. Busschots K., Vercammen J., Emiliani S., Benarous R., Engelborghs Y., Christ F., Debyser Z. The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J. Biol. Chem. 2005, 280:17841.
24. Calattini S., Betsem E.B., Froment A., Mauclere P., Tortevoye P., Schmitt C., Njouom R., Saib A., Gessain A. Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg. Infect. Dis. 2007, 13:1314.
25. Calmels B., Ferguson C., Laukkanen M.O., Adler R., Faulhaber M., Kim H.J., Sellers S., Hematti P., Schmidt M., von Kalle C., Akagi K., Donahue R.E., et al. Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells. Blood 2005, 106:2530.
26. Campbell M., Renshaw-Gegg L., Renne R., Luciw P.A. Characterization of the internal promoter of simian foamy viruses. J. Virol. 1994, 68:4811.
27. Chang J., Lee K.J., Jang K.L., Lee E.K., Baek G.H., Sung Y.C. Human foamy virus Bel1 transactivator contains a bipartite nuclear localization determinant which is sensitive to protein context and triple multimerization domains. J. Virol. 1995, 69:801.
28. Cherepanov P., Maertens G., Proost P., Devreese B., Van Beeumen J., Engelborghs Y., De Clercq E., Debyser Z. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 2003, 278:372.
29. Ciuffi A., Bushman F.D. Retroviral DNA integration: HIV and the role of LEDGF/p75. Trends Genet. 2006, 22:388.
30. Ciuffi A., Llano M., Poeschla E., Hoffmann C., Leipzig J., Shinn P., Ecker J.R., Bushman F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 2005, 11:1287.
31. Ciuffi A., Diamond T.L., Hwang Y., Marshall H.M., Bushman F.D. Modulating target site selection during human immunodeficiency virus DNA integration in vitro with an engineered tethering factor. Hum. Gene Ther. 2006, 17:960.
32. Coffin J.M., Hughes S.H., Varmus H.E. Retroviruses 1997, Cold Spring Habor Laboratory Press, New York, USA.
33. Cullen B.R. Human immunodeficiency virus as a prototypic complex retrovirus. J. Virol. 1991, 65:1053.
34. Cullen B. Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 1998, 249:203.
35. Cullen B. Nuclear mRNA export: Insights from virology. Trends Biochem. Sci. 2003, 28:419.
36. Cullen B.R. Nuclear RNA export. J. Cell Sci. 2003, 116:587.
37. Danckwardt S., Hentze M.W., Kulozik A.E. 3' End mRNA processing: Molecular mechanisms and implications for health and disease. EMBO J. 2008, 27:482.
38. Dave U.P., Akagi K., Tripathi R., Cleveland S.M., Thompson M.A., Yi M., Stephens R., Downing J.R., Jenkins N.A., Copeland N.G. Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy. PLoS Genet. 2009, 5:e1000491.
39. De Luca L., Barreca M.L., Ferro S., Christ F., Iraci N., Gitto R., Monforte A.M., Debyser Z., Chimirri A. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75. ChemMedChem 2009, 4:1311.
40. Derse D., Crise B., Li Y., Princler G., Lum N., Stewart C., McGrath C., Hughes S., Munroe D., Wu X. Human T-cell leukemia virus type 1 integration target sites in the human genome: Comparison with those of other retroviruses. J. Virol. 2007, 81:6731.
41. Enders J.F., Peebles T.C. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 1954, 86:277.
42. Enssle J., Jordan I., Mauer B., Rethwilm A. Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc. Natl. Acad. Sci. USA 1996, 93:4137.
43. Faschinger A., Rouault F., Sollner J., Lukas A., Salmons B., Gunzburg W.H., Indik S. Mouse mammary tumor virus integration site selection in human and mouse genomes. J. Virol. 2008, 82:1360.
44. Ferris A.L., Wu X., Hughes C.M., Stewart C., Smith S.J., Milne T.A., Wang G.G., Shun M.C., Allis C.D., Engelman A., Hughes S.H. Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration. Proc. Natl. Acad. Sci. USA 2010, 107:3135.
45. Flügel R.M., Maurer B., Bannert H., Rethwilm A., Schnitzler P., Darai G. Nucleotide sequence analysis of a cloned DNA fragment from human cells reveals homology to retrotransposons. Mol. Cell. Biol. 1987, 7:231.
46. Flügel R.M., Rethwilm A., Maurer B., Darai G. Nucleotide sequence analysis of the env gene and its flanking regions of the human spumaretrovirus reveals two novel genes. EMBO J. 1987, 6:2077.
47. Fujinaga K., Irwin D., Huang Y., Taube R., Kurosu T., Peterlin B.M. Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response element. Mol. Cell. Biol. 2004, 24:787.
48. Furger A., Monks J., Proudfoot N.J. The retroviruses human immunodeficiency virus type 1 and Moloney murine leukemia virus adopt radically different strategies to regulate promoter-proximal polyadenylation. J. Virol. 2001, 75:11735.
49. Furth P.A., Choe W.T., Rex J.H., Byrne J.C., Baker C.C. Sequences homologous to 5' splice sites are required for the inhibitory activity of papillomavirus late 3' untranslated regions. Mol. Cell. Biol. 1994, 14:5278.
50. Garber M.E., Jones K.A. HIV-1 Tat: Coping with negative elongation factors. Curr. Opin. Immunol. 1999, 11:460.
51. Garrett E.D., He F., Bogerd H.P., Cullen B.R. Transcriptional trans activators of human and simian foamy viruses contain a small, highly conserved activation domain. J. Virol. 1993, 67:6824.
52. Görlich D., Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 1999, 15:607.
53. Gruter P., Tabernero C., von Kobbe C., Schmitt C., Saavedra C., Bachi A., Wilm M., Felber B.K., Izaurralde E. TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol. Cell 1998, 1:649.
54. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997, 90:595.
55. Gunderson S.I., Polycarpou-Schwarz M., Mattaj I.W. U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase. Mol. Cell 1998, 1:255.
56. Hanly S.M., Rimsky L.T., Malim M.H., Kim J.H., Hauber J., Duc Dodon M., Le S.Y., Maizel J.V., Cullen B.R., Greene W.C. Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev. 1989, 3:1534.
57. Hartl M.J., Mayr F., Rethwilm A., Wöhrl B.M. Biophysical and enzymatic properties of the simian and prototype foamy virus reverse transcriptases. Retrovirology 2008, 7:5.
58. Hartl M.J., Bodem J., Jochheim F., Rethwilm A., Rösch P., Wöhrl B.M. Regulation of foamy virus protease activity by viral RNA-A novel and unique mechanism among retroviruses. J. Virol. 2011, 85:4462.
59. He F., Sun J.D., Garrett E.D., Cullen B.R. Functional organization of the Bel-1 trans activator of human foamy virus. J. Virol. 1993, 67:1896.
60. He F., Blair W.S., Fukushima J., Cullen B.R. The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein. J. Virol. 1996, 70:3902.
61. Heinkelein M., Leurs C., Rammling M., Peters K., Hanenberg H., Rethwilm A. Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids. J. Virol. 2002, 76:10069.
62. Hendrie P.C., Huo Y., Stolitenko R.B., Russell D.W. A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses. Mol. Ther. 2008, 16:534.
63. Heneine W., Switzer W.M., Sandstrom P., Brown J., Vedapuri S., Schable C.A., Khan A.S., Lerche N.W., Schweizer M., Neumann-Haefelin D., Chapman L.E., Folks T.M. Identification of a human population infected with simian foamy viruses. Nat. Med. 1998, 4:403.
64. Herchenröder O., Renne R., Loncar D., Cobb E.K., Murthy K.K., Schneider J., Mergia A., Luciw P.A. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): High homology to human foamy virus (HFV). Virology 1994, 201:187.
65. Holzschu D.L., Delaney M.A., Renshaw R.W., Casey J.W. The nucleotide sequence and spliced pol mRNA levels of the nonprimate spumavirus bovine foamy virus. J. Virol. 1998, 72:2177.
66. Hottiger M.O., Nabel G.J. Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J. Virol. 1998, 72:8252.
67. Indik S., Günzburg W., Salmons B., Rouault F. A novel, mouse mammary tumor virus encoded protein with Rev-like properties. Virology 2005, 337:1.
68. Jordan A., Defechereux P., Verdin E. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 2001, 20:1726.
69. Kabat D. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol. 1989, 148:1.
70. Kadosh D., Struhl K. Histone deacetylase activity of Rpd3 is important for transcriptional repression in vivo. Genes Dev. 1998, 12:797.
71. Kaehlcke K., Dorr A., Hetzer-Egger C., Kiermer V., Henklein P., Schnoelzer M., Loret E., Cole P.A., Verdin E., Ott M. Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol. Cell 2003, 12:167.
72. Kaida D., Berg M.G., Younis I., Kasim M., Singh L.N., Wan L., Dreyfuss G. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 2010, 468:664.
73. Kang Y., Cullen B.R. Derivation and functional characterization of a consensus DNA binding sequence for the tas transcriptional activator of simian foamy virus type 1. J. Virol. 1998, 72:5502.
74. Kang Y., Cullen B.R. The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences. Genes Dev. 1999, 13:1126.
75. Kang Y., Blair W.S., Cullen B.R. Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter. J. Virol. 1998, 72:504.
76. Kang Y., Bogerd H.P., Yang J., Cullen B.R. Analysis of the RNA binding specificity of the human tap protein, a constitutive transport element-specific nuclear RNA export factor. Virology 1999, 262:200.
77. Kang Y., Bogerd H.P., Cullen B.R. Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element. J. Virol. 2000, 74:5863.
78. Keller A., Partin K.M., Lochelt M., Bannert H., Flugel R.M., Cullen B.R. Characterization of the transcriptional trans activator of human foamy retrovirus. J. Virol. 1991, 65:2589.
79. Kennedy-Stoskopf S., Stoskopf M.K., Eckhaus M.A., Strandberg J.D. Isolation of a retrovirus and a herpesvirus from a captive California sea lion. J. Wildl. Dis. 1986, 22:156.
80. Kido K., Doerks A., Löchelt M., Flügel R.M. Identification and functional characterization of an intragenic DNA binding site for the spumaretroviral trans-activator in the human p57Kip2 gene. J. Biol. Chem. 2002, 277:12032.
81. Kido K., Bannert H., Gronostajski R.M., Flügel R.M. Bel1-mediated transactivation of the spumaretroviral internal promoter is repressed by nuclear factor I. J. Biol. Chem. 2003, 278:11836.
82. Kiernan R.E., Vanhulle C., Schiltz L., Adam E., Xiao H., Maudoux F., Calomme C., Burny A., Nakatani Y., Jeang K.T., Benkirane M., Van Lint C. HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 1999, 18:6106.
83. Konvalinka J., Löchelt M., Zentgraf H., Flügel R.M., Kräusslich H.G. Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J. Virol. 1995, 69:7264.
84. Kotsopoulou E., Kim V.N., Kingsman A.J., Kingsman S.M., Mitrophanous K.A. A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene. J. Virol. 2000, 74:4839.
85. Kupiec J.J., Kay A., Hayat M., Ravier R., Peries J., Galibert F. Sequence analysis of the simian foamy virus type 1 genome. Gene 1991, 101:185.
86. Lindemann D., Rethwilm A. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J. Virol. 1998, 72:4088.
87. Liu W., Worobey M., Li Y., Keele B.F., Bibollet-Ruche F., Guo Y., Goepfert P.A., Santiago M.L., Ndjango J.B., Neel C., Clifford S.L., Sanz C., et al. Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog. 2008, 4:e1000097.
88. Liu W., Backes P., Löchelt M. Importance of the major splice donor and redefinition of cis-acting sequences of gutless feline foamy virus vectors. Virology 2009, 394:208.
89. Löchelt M. Foamy virus transactivation and gene expression. Curr. Top. Microbiol. Immunol. 2003, 277:27.
90. Löchelt M., Aboud M., Flügel R.M. Increase in the basal transcriptional activity of the human foamy virus internal promoter by the homologous long terminal repeat promoter in cis. Nucleic Acids Res. 1993, 21:4226.
91. Löchelt M., Flügel R.M., Aboud M. The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection. J. Virol. 1994, 68:638.
92. Löwer R., Tonjes R.R., Korbmacher C., Kurth R., Löwer J. Identification of a Rev-related protein by analysis of spliced transcripts of the human endogenous retroviruses HTDV/HERV-K. J. Virol. 1995, 69:141.
93. Maertens G., Cherepanov P., Pluymers W., Busschots K., De Clercq E., Debyser Z., Engelborghs Y. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J. Biol. Chem. 2003, 278:33528.
94. Mancebo H.S., Lee G., Flygare J., Tomassini J., Luu P., Zhu Y., Peng J., Blau C., Hazuda D., Price D., Flores O. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 1997, 11:2633.
95. Marshall N.F., Dahmus M.E. C-terminal domain phosphatase sensitivity of RNA polymerase II in early elongation complexes on the HIV-1 and adenovirus 2 major late templates. J. Biol. Chem. 2000, 275:32430.
96. Maurer B., Serfling E., ter Meulen V., Rethwilm A. Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat. J. Virol. 1991, 65:6353.
97. McClure M.O., Bieniasz P.D., Schulz T.F., Chrystie I.L., Simpson G., Aguzzi A., Hoad J.G., Cunningham A., Kirkwood J., Weiss R.A. Isolation of a new foamy retrovirus from orangutans. J. Virol. 1994, 68:7124.
98. Mergia A., Pratt-Lowe E., Shaw K.E., Renshaw-Gegg L.W., Luciw P.A. cis-acting regulatory regions in the long terminal repeat of simian foamy virus type 1. J. Virol. 1992, 66:251.
99. Michel F., Crucifix C., Granger F., Eiler S., Mouscadet J.F., Korolev S., Agapkina J., Ziganshin R., Gottikh M., Nazabal A., Emiliani S., Benarous R., et al. Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor. EMBO J. 2009, 28:980.
100. Millevoi S., Vagner S. Molecular mechanisms of eukaryotic pre-mRNA 3' end processing regulation. Nucleic Acids Res. 2009, 38:2757.
101. Mitchell R.S., Beitzel B.F., Schröder A.R., Shinn P., Chen H., Berry C.C., Ecker J.R., Bushman F.D. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol. 2004, 2:E234.
102. Mok H.P., Lever A.M. Chromatin, gene silencing and HIV latency. Genome Biol. 2007, 8:228.
103. Moore M.J., Proudfoot N.J. Pre-mRNA processing reaches back to transcription and ahead to translation. Cell 2009, 136:688.
104. Mouinga-Ondeme A., Betsem E., Caron M., Makuwa M., Salle B., Renault N., Saib A., Telfer P., Marx P., Gessain A., Kazanji M. Two distinct variants of simian foamy virus in naturally infected mandrills (Mandrillus sphinx) and cross-species transmission to humans. Retrovirology 2010, 7:105.
105. Muranyi W., Flügel R.M. Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J. Virol. 1991, 65:727.
106. Muth V., Nadaud S., Grummt I., Voit R. Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. EMBO J. 2001, 20:1353.
107. Nazarov V., Wolff L. Novel integration sites at the distal 3' end of the c-myb locus in retrovirus-induced promonocytic leukemias. J. Virol. 1995, 69:3885.
108. Nitta T., Hofacre A., Hull S., Fan H. Identification and mutational analysis of a Rej response element in Jaagsiekte sheep retrovirus RNA. J. Virol. 2009, 83:12499.
109. Nowrouzi A., Dittrich M., Klanke C., Heinkelein M., Rammling M., Dandekar T., von Kalle C., Rethwilm A. Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 2006, 87:1339.
110. Ohno M., Fornerod M., Mattaj I.W. Nucleocytoplasmic transport: The last 200 nanometers. Cell 1998, 92:327.
111. Ott M., Schnölzer M., Garnica J., Fischle W., Emiliani S., Rackwitz H.R., Verdin E. Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol. 1999, 9:1489.
112. Pacheco B., Finzi A., McGee-Estrada K., Sodroski J. Species-specific inhibition of foamy viruses from South American monkeys by New World Monkey TRIM5{alpha} proteins. J. Virol. 2010, 84:4095.
113. Ping Y.H., Rana T.M. DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J. Biol. Chem. 2001, 276:12951.
114. Qiu J., Pintel D.J. Alternative polyadenylation of adeno-associated virus type 5 RNA within an internal intron is governed by the distance between the promoter and the intron and is inhibited by U1 small nuclear RNP binding to the intervening donor. J. Biol. Chem. 2004, 279:14889.
115. Rabson A.B., Graves B.J. Synthesis and processing of viral RNA. Retroviruses 1997, 205-262. Cold Spring Harbor Laboratory Press, Woodbury, NY. J.M. Coffin, S.H. Hughes, H.E. Varmus (Eds.).
116. Reed R. Coupling transcription, splicing and mRNA export. Curr. Opin. Cell Biol. 2003, 15:326.
117. Renne R., Friedl E., Schweizer M., Fleps U., Turek R., Neumann-Haefelin D. Genomic organization and expression of simian foamy virus type 3 (SFV-3). Virology 1992, 186:597.
118. Rethwilm A. The replication strategy of foamy viruses. Curr. Top. Microbiol. Immunol. 2003, 277:1.
119. Rethwilm A., Darai G., Rosen A., Maurer B., Flügel R.M. Molecular cloning of the genome of human spumaretrovirus. Gene 1987, 59:19.
120. Rethwilm A., Mori K., Maurer B., ter Meulen V. Transacting transcriptional activation of human spumaretrovirus LTR in infected cells. Virology 1990, 175:568.
121. Rethwilm A., Erlwein O., Baunach G., Maurer B., ter Meulen V. The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc. Natl. Acad. Sci. USA 1991, 88:941.
122. Rigo F., Martinson H.G. Functional coupling of last-intron splicing and 3'-end processing to transcription in vitro: The poly(A) signal couples to splicing before committing to cleavage. Mol. Cell. Biol. 2008, 28:849.
123. Rigo F., Martinson H.G. Polyadenylation releases mRNA from RNA polymerase II in a process that is licensed by splicing. RNA 2009, 15:823.
124. Rodriguez M.S., Dargemont C., Stutz F. Nuclear export of RNA. Biol. Cell 2004, 96:639.
125. Romen F., Backes P., Materniak M., Sting R., Vahlenkamp T.W., Riebe R., Pawlita M., Kuzmak J., Löchelt M. Serological detection systems for identification of cows shedding bovine foamy virus via milk. Virology 2007, 364:123.
126. Saib A., Peries J., de The H. A defective human foamy provirus generated by pregenome splicing. EMBO J. 1993, 12:4439.
127. Schmidt M., Herchenroder O., Heeney J., Rethwilm A. Long terminal repeat U3 length polymorphism of human foamy virus. Virology 1997, 230:167.
128. Schrom E.-M., Schied T., Weitner H., Spannaus R., Rethwilm A., Bohne J., Bodem J. Regulation of foamy virus polyadenylation: Major splice donor-mediated suppression at the 5'LTR 2011, (in revision).
129. Schulze A., Lemey P., Schubert J., McClure M.O., Rethwilm A., Bodem J. Complete nucleotide sequence and evolutionary analysis of a Gorilla foamy virus. J. Gen. Virol. 2011, 92:582.
130. Schweizer M., Turek R., Hahn H., Schliephake A., Netzer K.O., Eder G., Reinhardt M., Rethwilm A., Neumann-Haefelin D. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res. Hum. Retroviruses 1995, 11:161.
131. Sels F.T., Langer S., Schulz A.S., Silver J., Sitbon M., Friedrich R.W. Friend murine leukaemia virus is integrated at a common site in most primary spleen tumours of erythroleukaemic animals. Oncogene 1992, 7:643.
132. Sharma N., Nyborg J.K. The coactivators CBP/p300 and the histone chaperone NAP1 promote transcription-independent nucleosome eviction at the HTLV-1 promoter. Proc. Natl. Acad. Sci. USA 2008, 105:7959.
133. Sheldon L.A., Becker M., Smith C.L. Steroid hormone receptor-mediated histone deacetylation and transcription at the mouse mammary tumor virus promoter. J. Biol. Chem. 2001, 276:32423.
134. Spannaus R., Hartl M.J., Wöhrl B.M., Bodem J. In vitro and in vivo activation of foamy virus protease is independent of integrase 2011, Submitted.
135. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 1998, 12:599.
136. Struhl K., Moqtaderi Z. The TAFs in the HAT. Cell 1998, 94:1.
137. Switzer W.M., Bhullar V., Shanmugam V., Cong M.E., Parekh B., Lerche N.W., Yee J.L., Ely J.J., Boneva R., Chapman L.E., Folks T.M., Heneine W. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J. Virol. 2004, 78:2780.
138. Switzer W.M., Salemi M., Shanmugam V., Gao F., Cong M.E., Kuiken C., Bhullar V., Beer B.E., Vallet D., Gautier-Hion A., Tooze Z., Villinger F., et al. Ancient co-speciation of simian foamy viruses and primates. Nature 2005, 434:376.
139. Switzer W.M., Garcia A.D., Yang C., Wright A., Kalish M.L., Folks T.M., Heneine W. Coinfection with HIV-1 and simian foamy virus in West Central Africans. J. Infect. Dis. 2008, 197:1389.
140. Thümer L., Rethwilm A., Holmes E., Bodem J. The complete nucleotide sequence of a New World simian foamy virus. Virology 2007, 369:191.
141. Tobaly-Tapiero J., Bittoun P., Neves M., Guillemin M.C., Lecellier C.H., Puvion-Dutilleul F., Gicquel B., Zientara S., Giron M.L., de The H., Saib A. Isolation and characterization of an equine foamy virus. J. Virol. 2000, 74:4064.
142. Trobridge G.D., Miller D.G., Jacobs M.A., Allen J.M., Kiem H.P., Kaul R., Russell D.W. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. USA 2006, 103:1498.
143. Trusko S.P., Hoffman E.K., George D.L. Transcriptional activation of cKi-ras proto-oncogene resulting from retroviral promoter insertion. Nucleic Acids Res. 1989, 17:9259.
144. Vagner S., Ruegsegger U., Gunderson S.I., Keller W., Mattaj I.W. Position-dependent inhibition of the cleavage step of pre-mRNA 3'-end processing by U1 snRNP. RNA 2000, 6:178.
145. Verschoor E.J., Langenhuijzen S., van den Engel S., Niphuis H., Warren K.S., Heeney J.L. Structural and evolutionary analysis of an orangutan foamy virus. J. Virol. 2003, 77:8584.
146. Verschoor E.J., Langenhuijzen S., Bontjer I., Fagrouch Z., Niphuis H., Warren K.S., Eulenberger K., Heeney J.L. The phylogeography of orangutan foamy viruses supports the theory of ancient repopulation of Sumatra. J. Virol. 2004, 78:12712.
147. Vinciguerra P., Stutz F. mRNA export: An assembly line from genes to nuclear pores. Curr. Opin. Cell Biol. 2004, 16:285.
148. Wagner A., Doerks A., Aboud M., Alonso A., Tokino T., Flugel R.M., Lochelt M. Induction of cellular genes is mediated by the Bel1 transactivator in foamy virus-infected human cells. J. Virol. 2000, 74:4441.
149. Wang Z., Burge C.B. Splicing regulation: From a parts list of regulatory elements to an integrated splicing code. RNA 2008, 14:802.
150. Weichs an der Glon C., Monks J., Proudfoot N.J. Occlusion of the HIV poly(A) site. Genes Dev. 1991, 5:244.
151. Weis K. Regulating access to the genome: Nucleocytoplasmic transport throughout the cell cycle. Cell 2003, 112:441.
152. Winkler I., Bodem J., Haas L., Zemba M., Delius H., Flower R., Flügel R.M., Löchelt M. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J. Virol. 1997, 71:6727.
153. Wodrich H., Bohne J., Gumz E., Welker R., Kräusslich H.G. A new RNA element located in the coding region of a murine endogenous retrovirus can functionally replace the Rev/Rev-responsive element system in human immunodeficiency virus type 1 Gag expression. J. Virol. 2001, 75:10670.
154. Wolffe H. Chromatin: Structure and Function 1999, Academic Press Inc., London, UK.
155. Wong K., Sharma A., Awasthi S., Matlock E.F., Rogers L., Van Lint C., Skiest D.J., Burns D.K., Harrod R. HIV-1 Tat interactions with p300 and PCAF transcriptional coactivators inhibit histone acetylation and neurotrophin signaling through CREB. J. Biol. Chem. 2005, 280:9390.
156. Wu X., Li Y., Crise B., Burgess S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003, 300:1749.
157. Yang J., Bogerd H.P., Peng S., Wiegand H., Truant R., Cullen B.R. An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc. Natl. Acad. Sci. USA 1999, 96:13404.
158. Yu S.F., Baldwin D.N., Gwynn S.R., Yendapalli S., Linial M.L. Human foamy virus replication: A pathway distinct from that of retroviruses and hepadnaviruses. Science 1996, 271:1579.
159. Zhao J., Hyman L., Moore C. Formation of mRNA 3' ends in eukaryotes: Mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol. Mol. Biol. Rev. 1999, 63:405.
160. Zhu Y., Pe'ery T., Peng J., Ramanathan Y., Marshall N., Marshall T., Amendt B., Mathews M.B., Price D.H. Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 1997, 11:2622.
161. Zolotukhin A.S., Michalowski D., Smulevitch S., Felber B.K. Retroviral constitutive transport element evolved from cellular TAP(NXF1)-binding sequences. J. Virol. 2001, 75:5567.